Job
Manager, CMC Quality, Pulmovant
- Organisation
- Pulmovant
- Where
- United States
- Mode
- Remote
- Funding
- Paid
- For
- Professionals
- Deadline
- 20 December 2026 (58 days left)
- Source
- Remote job from Himalayas
About
Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant ’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 3 PHrontier global clinical trial in PH-ILD, but with potential broad applicabil
Eligibility, full details and the official apply link
Members see the complete record, the direct link to apply, a personal match score and deadline reminders.
Unlock it free See plans